Bronchiectasis | Serrapeptase.info
Links shared publicly online about this topic.
- 379total visits
Bronchiectasis | Serrapeptase.info
View full resource at serrapeptase.info
Tags: Bronchiectasis
Most Recently Shared on April 8, 2011 at 7:37 pm By:
Suzan Macco RN, CNHP, Loomis Digestive Health Specialist
Bronchiectasis & Serrapeptase http://bit.ly/eI5bLN
COPD Foundation Announces Landmark Measure: 1,000th Patient Enrolled in Bronchiectasis Research Registry | Business Wire
businesswire.com — “With Chronic Obstructive Pulmonary Disease (COPD) as the third leading cause of death in the United States and the only chronic disease growing in mor” View full resource at businesswire.com
Most Recently Shared on October 20, 2011 at 3:39 pm By:
OrganizedWisdom COPD OW Health
COPD Foundation Announces Landmark Measure: 1,000th Patient Enrolled in Bronchiectasis Research Registry: WASHIN... http://t.co/YASHMcV3
Hypertonic saline for bronchiectasis | Practice | Nursing Times
nursingtimes.net — “A nurse-led initiative has demonstrated that nebulised hypertonic saline can help patients with bronchiectasis to clear secretions, improving their quality of life” View full resource at nursingtimes.net
Most Recently Shared on August 4, 2011 at 11:35 am By:
Latest practice: Hypertonic saline for bronchiectasis http://bit.ly/pxBBru
Infectious Disease Article | Pneumonia
mdlinx.com — “First Case of Segniliparus rotundus Pneumonia in a Patient with Bronchiectasis” View full resource at mdlinx.com
Most Recently Shared on July 18, 2011 at 11:32 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
First Case of Segniliparus rotundus Pneumonia in a Patient with Bronchiectasis: Journal of Clinical Microbiology http://bit.ly/oSvwx3 #ID
Aradigm Reports Successful ORBIT-1 Bronchiectasis Study With Inhaled Liposomal Ciprofloxacin
medicalnewstoday.com — “Aradigm Corporation (OTCBB:ARDM) (the Company) today announced positive top line data from its recently concluded Phase 2b study (Once-Daily Respiratory Bronchiectasis Inhalation Treatment - ORB” View full resource at medicalnewstoday.com
Most Recently Shared on June 17, 2011 at 4:05 pm By:
MNT Cystic Fibrosis Health News
Aradigm Reports Successful ORBIT-1 Bronchiectasis Study With Inhaled Liposomal Ciprofloxacin http://mnt.to/3Xmt #cysticfibrosis
Aradigm demonstrates top line data from ORBIT-1 ARD-3100 Phase 2b study for bronchiectasis
news-medical.net — “Aradigm Corporation today announced positive top line data from its recently concluded Phase 2b study (Once-Daily Respiratory Bronchiectasis Inhalation Treatment - ORBIT-1) with Aradigm's ciprofloxacin for inhalation (CFI, ARD-3100, LipoquinTM) in patients with non-cystic fibrosis bronchiectasis (BE).” View full resource at news-medical.net
Most Recently Shared on June 16, 2011 at 1:40 pm By:
Aradigm demonstrates top line data from ORBIT-1 ARD-3100 Phase 2b study for bronchiectasis: Aradigm Corporation ... http://bit.ly/m6m5x4
Aradigm Reports Successful ORBIT-1 Bronchiectasis Study with Inhaled Liposomal Ciprofloxacin - Drugs.com MedNews
drugs.com — “Both ARD-3100 Doses Met Primary Endpoint 2 mL Dose Found Equipotent to 3 mL Dose, with Excellent Safety and Tolerability Jun 16, 2011 - Aradigm Corporation (OTC” View full resource at drugs.com
Most Recently Shared on June 16, 2011 at 1:08 pm By:
Drugs and Devices OW OW Health
Aradigm Reports Successful ORBIT-1 Bronchiectasis Study with Inhaled Liposomal Ciprofloxacin: Both ARD-310... http://bit.ly/mBxNZC #drug
Aradigm Receives FDA Orphan Drug Designation For Ciprofloxacin For Inhalation In Bronchiectasis
medicalnewstoday.com — “Aradigm Corporation (OTCBB:ARDM) (the Company) today announced it has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for ciprofloxacin for inhalation for the m” View full resource at medicalnewstoday.com
Most Recently Shared on June 7, 2011 at 3:05 pm By:
MNT Cystic Fibrosis Health News
Aradigm Receives FDA Orphan Drug Designation For Ciprofloxacin For Inhalation In Bronchiectasis http://mnt.to/3WSg #cysticfibrosis
NTM Info & Research | Facebook
facebook.com — “NTM Info & Research - Information about research and health for NTM lung disease and NTM-related diseases like CF, bronchiectasis and PCD. | Facebook” View full resource at facebook.com
Most Recently Shared on June 1, 2011 at 4:04 pm By:
Philip Leitman - NTM Info & Research Support
Have you liked us on Facebook yet? http://www.facebook.com/pages/NTM-Info-Research/20971945418
Aradigm Completes Enrollment In Phase 2b Study Of Inhaled Ciprofloxacin For The Management Of Respiratory Infections In Bronchiectasis
medicalnewstoday.com — “Aradigm Corporation (OTCBB:ARDM) announced the last patient was enrolled in a Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (CFI, ARD-3100) in patients with non” View full resource at medicalnewstoday.com
Most Recently Shared on March 23, 2011 at 4:05 pm By:
MNT Cystic Fibrosis Health News
Aradigm Completes Enrollment In Phase 2b Study Of Inhaled Ciprofloxacin For The Management Of Respiratory Infections I... http://mnt.to/3SDy
Enrollment complete in Aradigm's inhaled ciprofloxacin Phase 2b study in non-cystic fibrosis bronchiectasis
news-medical.net — “Aradigm Corporation announced the last patient was enrolled in a Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (CFI, ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE), a severe progressive respiratory disease for which there is currently no approved treatment in the U.S.” View full resource at news-medical.net
Most Recently Shared on March 23, 2011 at 4:49 am By:
Enrollment complete in Aradigm's inhaled ciprofloxacin Phase 2b study in non-cystic fibrosis bronchiectasis: Ara... http://bit.ly/hMkIse
A Randomized Controlled Trial of Nebulized Gentamicin in Non-Cystic Fibrosis Bronchiectasis -- Murray et al. 183 (4): 491 -- American Journal of Respiratory and Critical Care Medicine
ajrccm.atsjournals.org — “A Randomized Controlled Trial of Nebulized Gentamicin in Non-Cystic Fibrosis Bronchiectasis -- Murray et al. 183 (4): 491 -- American Journal of Respiratory and Critical Care Medicine” View full resource at ajrccm.atsjournals.org
Most Recently Shared on February 23, 2011 at 10:51 pm By:
A Randomized Controlled Trial of Nebulized Gentamicin in Non–Cystic Fibrosis Bronchiectasis. http://bit.ly/gyxof0
Aradigm to Report Expanded Results from Successful Six-Month Phase 2b Bronchiectasis Study at Biotech Showcase 2011 - Drugs.com MedNews
drugs.com — “Primary Endpoint Reduction in Bacterial Load - Met Statistically Significant Secondary Endpoints of Delay to First Exacerbation and Reduction in the Need for Ot” View full resource at drugs.com
Most Recently Shared on January 6, 2011 at 2:07 pm By:
Drugs and Devices OW OW Health
Aradigm to Report Expanded Results from Successful Six-Month Phase 2b Bronchiectasis Study at Biotech Show... http://bit.ly/ejHmso #drug
Infectious Disease Article | Bronchiectasis
mdlinx.com — “Bronchiectasis and pulmonary exacerbations in children and young adults with CF” View full resource at mdlinx.com
Most Recently Shared on December 16, 2010 at 4:46 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Bronchiectasis and pulmonary exacerbations in children and young adults with CF: Chest http://bit.ly/ehQAlw #ID
Aradigm Reports Successful Phase 2b Bronchiectasis Study with Inhaled Liposomal Ciprofloxacin - Drugs.com MedNews
drugs.com — “Primary Endpoint Reduction in Bacterial Load - Met Positive Trends Observed in Time to First Exacerbation and Reduced Number of Exacerbations Statistically Sign” View full resource at drugs.com
Most Recently Shared on October 20, 2010 at 1:06 pm By:
Drugs and Devices OW OW Health
Aradigm Reports Successful Phase 2b Bronchiectasis Study with Inhaled Liposomal Ciprofloxacin: Primary Endpoi... http://bit.ly/9rT6K7 #drug
Advertisement
